A LIMITED ACCESS PHASE II TRIAL OF CISPLATIN AND NAVELBINE (VINORELBINE) IN ADVANCED AND RECURRENT SQUAMOUS CELL CARCINOMA OF THE CERVIX
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Cisplatin (Primary) ; Vinorelbine (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 05 Mar 2008 Status changed from in progress to completed, according to ClinicalTrials.gov
- 10 Sep 2005 New trial record.